Cargando…

Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience

OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Kunyang, Wang, Xu, Yang, Zhongsheng, Zhong, Yuming, Liu, Yifu, Sun, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249187/
https://www.ncbi.nlm.nih.gov/pubmed/37287019
http://dx.doi.org/10.1186/s12957-023-03060-3
_version_ 1785055507159973888
author Lei, Kunyang
Wang, Xu
Yang, Zhongsheng
Zhong, Yuming
Liu, Yifu
Sun, Ting
author_facet Lei, Kunyang
Wang, Xu
Yang, Zhongsheng
Zhong, Yuming
Liu, Yifu
Sun, Ting
author_sort Lei, Kunyang
collection PubMed
description OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patients with intermediate and high complexity RCC who underwent RATE and RAPN. The perioperative, oncological, and pathological outcomes of the two groups were compared, and univariate and multivariate analyses were used to evaluate the risk factors for warm ischemia time (WIT) > 25 min. RESULTS: Compared with RAPN group, patients in RATE group had shorter operative time (P < 0.001), shorter WIT (P < 0.001), and less estimated blood loss (EBL) (P < 0.001). The decrease rate of estimated glomerular filtration rate (eGFR) in RATE group was better than that in RAPN group (P < 0.001). Multivariable analysis showed that RAPN and higher PADUA score were independent risk factors for WIT > 25 min (both P < 0.001). The rate of positive surgical margin was similar between the two groups, but the local recurrence rate of the RATE group was higher than that of the RAPN group (P = 0.027). CONCLUSIONS: RATE and RAPN have similar oncological outcomes for the treatment of intermediate and high complexity RCC. In addition, RATE was superior to RAPN in perioperative outcomes.
format Online
Article
Text
id pubmed-10249187
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102491872023-06-09 Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience Lei, Kunyang Wang, Xu Yang, Zhongsheng Zhong, Yuming Liu, Yifu Sun, Ting World J Surg Oncol Research OBJECTIVES: To compare the perioperative and oncological outcomes of robotic-assisted tumor enucleation (RATE) and robotic-assisted partial nephrectomy (RAPN) in the treatment of intermediate and high complexity renal cell carcinoma (RCC). METHODS: We retrospectively collected the data of 359 patients with intermediate and high complexity RCC who underwent RATE and RAPN. The perioperative, oncological, and pathological outcomes of the two groups were compared, and univariate and multivariate analyses were used to evaluate the risk factors for warm ischemia time (WIT) > 25 min. RESULTS: Compared with RAPN group, patients in RATE group had shorter operative time (P < 0.001), shorter WIT (P < 0.001), and less estimated blood loss (EBL) (P < 0.001). The decrease rate of estimated glomerular filtration rate (eGFR) in RATE group was better than that in RAPN group (P < 0.001). Multivariable analysis showed that RAPN and higher PADUA score were independent risk factors for WIT > 25 min (both P < 0.001). The rate of positive surgical margin was similar between the two groups, but the local recurrence rate of the RATE group was higher than that of the RAPN group (P = 0.027). CONCLUSIONS: RATE and RAPN have similar oncological outcomes for the treatment of intermediate and high complexity RCC. In addition, RATE was superior to RAPN in perioperative outcomes. BioMed Central 2023-06-08 /pmc/articles/PMC10249187/ /pubmed/37287019 http://dx.doi.org/10.1186/s12957-023-03060-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lei, Kunyang
Wang, Xu
Yang, Zhongsheng
Zhong, Yuming
Liu, Yifu
Sun, Ting
Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title_full Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title_fullStr Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title_full_unstemmed Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title_short Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
title_sort robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249187/
https://www.ncbi.nlm.nih.gov/pubmed/37287019
http://dx.doi.org/10.1186/s12957-023-03060-3
work_keys_str_mv AT leikunyang roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience
AT wangxu roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience
AT yangzhongsheng roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience
AT zhongyuming roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience
AT liuyifu roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience
AT sunting roboticassistedtumorenucleationversusroboticassistedpartialnephrectomyforintermediateandhighcomplexityrenalcellcarcinomaasingleinstitutionexperience